Clinical Trials Browser

Triple Negative Breast Neoplasms × mavorixafor × Breast × Clear all

NCT05103917 2021-11-02

A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC

Phase 1/2 Unknown

Triple Negative Breast Neoplasms